Authors/Disclosures
|
Kristin N. Heller, PhD
(Nationwide Children's Hospital)
|
No disclosure on file |
|
Roshan L. Koul, MD, DM, FRCPCH
(Sultan Qaboos University Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Vinod Malik
(Nationwide Childrens Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
K. Reed Clark, PhD
|
No disclosure on file |
|
Shaun Hussain, MD
|
Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences. |
|
Louise R. Rodino-Klapac
(Sarepta Therapeutics)
|
Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care. |
|
Jerry R. Mendell, MD, FAAN
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |